Searched for
CLINICAL TRIAL COSTS
Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...- FDA Panel votes in favor of a $949 Cancer detecting blood test, but is Galleri ready for approval?Cancer cells can leave tiny fragments of DNA in the bloodstream. According to USA Today, Galleri studies chemical patterns found on these f...
- AI-based drug developer Basecamp valued at $800 million after $140 million funding roundThe oversubscribed round was led by S32, with participation from Nvidia, Anthropic's Anthology Fund, Catalio Capital Management, the NATO I...
- Bharat Biotech is 'back in action' after Covid reset: Krishna Ella on TB vaccine, Nipah-Ebola shots, gene therapy, IPO plans & what’s nextBharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...
- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
- Bernie Marcus was fired from his job in 1978, then built Home Depot and an $11 billion fortune — now his foundation is putting nearly $30 million into heart research, reviving his early dream of medicineBernie Marcus was fired from Handy Dan in 1978, a setback that helped push him toward cofounding Home Depot and building an $11 billion for...
- Bengaluru-based startup leans on cancer-sniffing dogs and AI for early detectionBilly, Jessie and Banu are part of a team of beagles, labradors, Dutch shepherds and other dog breeds being trained by startup Dognosis to ...
- For kidney patients, the biggest change may be coming: New artificial kidney implant will filter blood continuosly without regular hospital dialysisFor kidney patients, the biggest change may be coming in the form of Holly, a surgically implanted artificial kidney designed to filter blo...
- Jubilant Pharmova shares decline 6% after Q1 profits falls 45% YoYJubilant Pharmova shares fell after Q1 profit plunged 45% YoY to Rs 56 crore, despite revenue rising 17% to Rs 2,229 crore. The profit decl...
- In 2017, two parents asked scientist Stanley Crooke to create treatments for their children's rare mutations. Years later, a custom drug cut one boy's seizures by 90% and helped him walk on his own for the first timeMedicine is undergoing a profound transformation by shifting focus from populations to individual patients. A novel custom drug for rare ge...
- Forget Nvidia chips, China's next big race is being slowed down by an unlikely rival: monkeysLab primate prices in China have surged over 1,000% in eight years, with a single cynomolgus macaque now costing around Rs 22 lakh. The sho...
- In 2009, a Navy veteran's low-cost invention helped thousands get glasses in places without eye doctorsUSee Vision Kit: Retired US Navy and Marine Corps officer, Kevin White, has pioneered a vision testing system aimed at providing affordable...
- Can you get rid of cavities without drilling? Scientists find an 'easy and inexpensive' way to treat tooth decay in secondsA new study highlights silver diamine fluoride as a quick, painless dental treatment. This liquid application effectively stops early child...
- Bye-bye painful dentist visit: A simple liquid could stop tooth decay; no drilling or injections needed for many cavitiesA major US clinical trial has found that silver diamine fluoride, a liquid painted onto cavities in seconds, stopped tooth decay in more th...
- Can AI shorten India's rare disease diagnosis journey? New tool aims to do just thatSanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...
- FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drugThe US FDA approved an at-home starting dose for Eisai and Biogen's Alzheimer's drug. This new subcutaneous formulation allows patients to ...
- Pharma body renews push for data protectionLeading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...
- Clinical trials on naive Indians zoomNumber of clinical trials conducted by global pharma companies in India double in a year.
Load More
